z-logo
Premium
Long‐term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best’s disease: 3‐year follow‐up
Author(s) -
RuizMoreno Oscar,
Calvo Pilar,
Ferrández Blanca,
Torrón Clemencia
Publication year - 2012
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2011.02363.x
Subject(s) - medicine , metamorphopsia , ranibizumab , ophthalmology , choroidal neovascularization , visual acuity , fluorescein angiography , fundus (uterus) , macular degeneration , surgery , bevacizumab , chemotherapy

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here